Michael Rape

Michael Rape is a Professor of Molecular Therapeutics at the University of California, Berkeley, in the Department of BIO. His research focuses on ubiquitin-dependent control of cell fate decisions, particularly in metazoan development. His laboratory investigates the molecular mechanisms underlying regulated cell cycle transitions and the signaling pathways that direct the differentiation of human embryonic stem cells. Dr. Rape's work emphasizes the role of ubiquitylation in human development and its misregulation in diseases, including cancer and pediatric conditions. He has developed innovative strategies to modulate pathological cell fate decisions and has contributed to the identification of key ubiquitylation enzymes and their substrates.

Michael Rape is a researcher at UC Berkeley, focusing on ubiquitin-mediated processes. His work explores the mechanisms of ubiquitin chain formation, the role of E2 enzymes, and the functional significance of different ubiquitin linkages. He investigates how ubiquitylation regulates cell cycle control, transcription factor activation, and protein quality control. His research also examines the interplay between ubiquitin signaling and disease, particularly in development and cellular regulation. Key areas include the anaphase-promoting complex, CDC48/p97, and ubiquitin-selective chaperones. His studies highlight the complexity of ubiquitin codes and their impact on proteasomal targeting and signaling.